These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 19283523)

  • 21. Admission glycemia and markers of inflammation are independent outcome predictors in primary PCI in non-diabetic patients.
    Corrada E; Cappelleri A; Belli G; Genovese S; Barbaro C; Gasparini G; Pagnotta P; Rossi M; Zavalloni D; Presbitero P
    Minerva Cardioangiol; 2008 Oct; 56(5):445-52. PubMed ID: 18813179
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ST changes before and during primary percutaneous coronary intervention predict final infarct size in patients with ST elevation myocardial infarction.
    Terkelsen CJ; Kaltoft AK; Nørgaard BL; Bøttcher M; Lassen JF; Clausen K; Nielsen SS; Thuesen L; Nielsen TT; Bøtker HE; Andersen HR
    J Electrocardiol; 2009; 42(1):64-72. PubMed ID: 18984067
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does glucose level at hospital discharge predict one-year mortality in patients with diabetes mellitus treated with percutaneous coronary intervention for ST-segment elevation myocardial infarction?
    Gasior M; Pres D; Stasik-Pres G; Lech P; Gierlotka M; Lekston A; Hawranek M; Tajstra M; Kalarus Z; Poloński L
    Kardiol Pol; 2008 Jan; 66(1):1-8; discussion 9-11. PubMed ID: 18266182
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictive value of the index of microcirculatory resistance in patients with ST-segment elevation myocardial infarction.
    Fearon WF; Shah M; Ng M; Brinton T; Wilson A; Tremmel JA; Schnittger I; Lee DP; Vagelos RH; Fitzgerald PJ; Yock PG; Yeung AC
    J Am Coll Cardiol; 2008 Feb; 51(5):560-5. PubMed ID: 18237685
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contribution of angiographic and electrocardiographic parameters of reperfusion to prediction of mortality and morbidity after acute ST-elevation myocardial infarction: Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction trial.
    Brener SJ; Westerhout CM; Fu Y; Todaro TG; Moliterno DJ; Wagner GS; Granger CB; Armstrong PW;
    Am Heart J; 2009 Nov; 158(5):755-60. PubMed ID: 19853693
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanism involved in the paradoxical effects of active smoking following primary angioplasty: a subanalysis of the protection of distal embolization in high-risk patients with acute myocardial infarction trial.
    Albertal M; Cura F; Escudero AG; Thierer J; Trivi M; Padilla LT; Belardi J;
    J Cardiovasc Med (Hagerstown); 2008 Aug; 9(8):810-2. PubMed ID: 18607246
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predischarge QRS score and risk for heart failure after first ST-elevation myocardial infarction.
    Kalogeropoulos AP; Chiladakis JA; Sihlimiris I; Koutsogiannis N; Alexopoulos D
    J Card Fail; 2008 Apr; 14(3):225-31. PubMed ID: 18381186
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Left ventricular ejection fraction to predict early mortality in patients with non-ST-segment elevation acute coronary syndromes.
    Bosch X; Théroux P
    Am Heart J; 2005 Aug; 150(2):215-20. PubMed ID: 16086920
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Simple risk stratification at admission to identify patients with reduced mortality from primary angioplasty.
    Thune JJ; Hoefsten DE; Lindholm MG; Mortensen LS; Andersen HR; Nielsen TT; Kober L; Kelbaek H;
    Circulation; 2005 Sep; 112(13):2017-21. PubMed ID: 16186438
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transferring patients with ST-segment elevation myocardial infarction for mechanical reperfusion: a meta-regression analysis of randomized trials.
    De Luca G; Biondi-Zoccai G; Marino P
    Ann Emerg Med; 2008 Dec; 52(6):665-76. PubMed ID: 19027496
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ischemia modified albumin is a sensitive marker of myocardial ischemia after percutaneous coronary intervention.
    Sinha MK; Gaze DC; Tippins JR; Collinson PO; Kaski JC
    Circulation; 2003 May; 107(19):2403-5. PubMed ID: 12742986
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic syndrome is a predictor for an ECG sign of no-reflow after primary PCI in patients with acute ST-elevation myocardial infarction.
    Tartan Z; Ozer N; Uyarel H; Akgul O; Gul M; Cetin M; Kasikcioglu H; Cam N
    Nutr Metab Cardiovasc Dis; 2008 Jul; 18(6):441-7. PubMed ID: 17981019
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validated risk score predicts the development of congestive heart failure after presentation with unstable angina or non-ST-elevation myocardial infarction: results from OPUS-TIMI 16 and TACTICS-TIMI 18.
    Wylie JV; Murphy SA; Morrow DA; de Lemos JA; Antman EM; Cannon CP
    Am Heart J; 2004 Jul; 148(1):173-80. PubMed ID: 15215808
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship of admission haematological indices with infarct-related artery patency in patients with acute ST-segment elevation myocardial infarction treated with primary angioplasty.
    Maden O; Kacmaz F; Selcuk MT; Selcuk H; Metin F; Tufekcioglu O; Atak R; Balbay Y; Ilkay E
    Coron Artery Dis; 2007 Dec; 18(8):639-44. PubMed ID: 18004115
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic value of admission myeloperoxidase levels in patients with ST-segment elevation myocardial infarction and cardiogenic shock.
    Dominguez-Rodriguez A; Samimi-Fard S; Abreu-Gonzalez P; Garcia-Gonzalez MJ; Kaski JC
    Am J Cardiol; 2008 Jun; 101(11):1537-40. PubMed ID: 18489929
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence and prognostic implications of non-sustained ventricular tachycardia in ST-segment elevation myocardial infarction after revascularization with either fibrinolysis or primary angioplasty.
    Høfsten DE; Wachtell K; Lund B; Mølgaard H; Egstrup K
    Eur Heart J; 2007 Feb; 28(4):407-14. PubMed ID: 17227787
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical study on value of severity of patient with coronary artery disease evaluated with the thrombosis in myocardial infarction risk score].
    Zheng XY; Meng XK; Li WG; Yang J; Wei G; Fang R
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Apr; 16(4):239-41. PubMed ID: 15068722
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors of in-hospital mortality after percutaneous coronary intervention for cardiogenic shock.
    Valente S; Lazzeri C; Vecchio S; Giglioli C; Margheri M; Bernardo P; Comeglio M; Chiocchini S; Gensini GF
    Int J Cardiol; 2007 Jan; 114(2):176-82. PubMed ID: 16737749
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of ischemia modified albumin to ST-segment resolution after mechanical reperfusion in patients with ST-segment elevation myocardial infarction.
    Dominguez-Rodriguez A; Kaski JC; Abreu-Gonzalez P; Samimi-Fard S
    Atherosclerosis; 2009 Apr; 203(2):576-80. PubMed ID: 18789442
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Percutaneous coronary intervention-related time delay, patient's risk profile, and survival benefits of primary angioplasty vs lytic therapy in ST-segment elevation myocardial infarction.
    De Luca G; Cassetti E; Marino P
    Am J Emerg Med; 2009 Jul; 27(6):712-9. PubMed ID: 19751630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.